Nanolipoprotein particle (NLP) vaccine confers protection against Yersinia pestis aerosol challenge in a BALB/c mouse model

IntroductionYersinia pestis is the etiological agent of plague, a disease that remains a concern as demonstrated by recent outbreaks in Madagascar. Infection with Y. pestis results in a rapidly progressing illness that can only be successfully treated with antibiotics given shortly after symptom ons...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sergei S. Biryukov, Amy Rasley, Michael L. Davies, Christopher P. Klimko, Jennifer L. Dankmeyer, Melissa Hunter, Nathaniel O. Rill, Jennifer L. Shoe, Jeremy Miller, Yuli Talyansky, Barbara Sullinger, Matheo Herrera, Daniel Huang, Leslie Bautista, Lucy Pepe, Sandra K. G. Peters, Christian J. Xander, Elsie E. Martinez, Ronald G. Toothman, Kevin D. Mlynek, Joel A. Bozue, Ju Qiu, Nicholas O. Fischer, Christopher K. Cote
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Immunology
Subjects:	plague Yersinia pestis vaccine nanolipoprotein particle mice pneumonic
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1603710/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Nanolipoprotein particle (NLP) vaccine confers protection against Yersinia pestis aerosol challenge in a BALB/c mouse model

Similar Items